Your browser doesn't support javascript.
loading
The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice.
Gonzalez-Ericsson, Paula I; Stovgaard, Elisabeth S; Sua, Luz F; Reisenbichler, Emily; Kos, Zuzana; Carter, Jodi M; Michiels, Stefan; Le Quesne, John; Nielsen, Torsten O; Laenkholm, Anne-Vibeke; Fox, Stephen B; Adam, Julien; Bartlett, John Ms; Rimm, David L; Quinn, Cecily; Peeters, Dieter; Dieci, Maria V; Vincent-Salomon, Anne; Cree, Ian; Hida, Akira I; Balko, Justin M; Haynes, Harry R; Frahm, Isabel; Acosta-Haab, Gabriela; Balancin, Marcelo; Bellolio, Enrique; Yang, Wentao; Kirtani, Pawan; Sugie, Tomoharu; Ehinger, Anna; Castaneda, Carlos A; Kok, Marleen; McArthur, Heather; Siziopikou, Kalliopi; Badve, Sunil; Fineberg, Susan; Gown, Allen; Viale, Giuseppe; Schnitt, Stuart J; Pruneri, Giancarlo; Penault-Llorca, Frederique; Hewitt, Stephen; Thompson, E Aubrey; Allison, Kimberly H; Symmans, William F; Bellizzi, Andrew M; Brogi, Edi; Moore, David A; Larsimont, Denis; Dillon, Deborah A.
Affiliation
  • Gonzalez-Ericsson PI; Breast Cancer Research Program, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Stovgaard ES; Department of Pathology, Herlev and Gentofte Hospital, University of Copenhagen, Herlev, Denmark.
  • Sua LF; Department of Pathology and Laboratory Medicine, Fundación Valle del Lili, and Faculty of Health Sciences, Universidad ICESI, Cali, Colombia.
  • Reisenbichler E; Department of Pathology, Yale School of Medicine, New Haven, CT, USA.
  • Kos Z; Department of Pathology, BC Cancer Agency, Vancouver, Canada.
  • Carter JM; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
  • Michiels S; Biostatistics and Epidemiology Service, Centre de Recherche en Epidémiologie et Santé des Populations, Gustave Roussy, Université Paris-Sud, Villejuif, France.
  • Le Quesne J; Leicester Cancer Research Centre, University of Leicester, Leicester, UK.
  • Nielsen TO; MRC Toxicology Unit, University of Cambridge, Leicester, UK.
  • Laenkholm AV; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.
  • Fox SB; Department of Surgical Pathology, Zealand University Hospital, Roskilde, Denmark.
  • Adam J; Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Bartlett JM; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.
  • Rimm DL; Department of Pathology, Gustave Roussy, Grand Paris, France.
  • Quinn C; Ontario Institute for Cancer Research, Toronto, Canada.
  • Peeters D; Edinburgh Cancer Research Centre, Institute of Genetics and Molecular Medicine, Edinburgh, UK.
  • Dieci MV; Department of Pathology, Yale School of Medicine, New Haven, CT, USA.
  • Vincent-Salomon A; Department of Pathology, St Vincent's University Hospital and University College Dublin, Dublin, Ireland.
  • Cree I; HistoGeneX NV, Antwerp, Belgium.
  • Hida AI; AZ Sint-Maarten Hospital, Mechelen, Belgium.
  • Balko JM; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy.
  • Haynes HR; Medical Oncology 2, Istituto Oncologico Veneto - IRCCS, Padova, Italy.
  • Frahm I; Department of Pathology, Insitut Curie, Paris, France.
  • Acosta-Haab G; International Agency for Research on Cancer (IARC), World Health Organization, Lyon, France.
  • Balancin M; Department of Pathology, Matsuyama Shimin Hospital, Matsuyama, Japan.
  • Bellolio E; Breast Cancer Research Program, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Yang W; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Kirtani P; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Sugie T; Department of Cellular Pathology, North Bristol NHS Trust, Bristol, UK.
  • Ehinger A; Translational Health Sciences, University of Bristol, Bristol, UK.
  • Castaneda CA; Department of Pathology, Sanatorio Mater Dei, Buenos Aires, Argentina.
  • Kok M; Department of Pathology, Hospital de Oncología Maria Curie, Buenos Aires, Argentina.
  • McArthur H; Department of Pathology, Faculty of Medicine, University of São Paulo, São Paulo, Brazil.
  • Siziopikou K; Department of Pathology, Universidad de La Frontera, Temuco, Chile.
  • Badve S; Department of Pathology, Fudan University Shanghai Cancer Centre, Shanghai, PR China.
  • Fineberg S; Department of Histopathology, Manipal Hospitals Dwarka, New Delhi, India.
  • Gown A; Breast Surgery, Kansai Medical University Hospital, Hirakata, Japan.
  • Viale G; Department of Clinical Genetics and Pathology, Skane University Hospital, Lund University, Lund, Sweden.
  • Schnitt SJ; Department of Medical Oncology, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru.
  • Pruneri G; Divisions of Medical Oncology, Tumor Biology & Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Penault-Llorca F; Medical Oncology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Hewitt S; Department of Pathology, Breast Pathology Section, Northwestern University, Chicago, IL, USA.
  • Thompson EA; Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, IN, USA.
  • Allison KH; Department of Pathology, Montefiore Medical Center and the Albert Einstein College of Medicine, Bronx, NY, USA.
  • Symmans WF; PhenoPath Laboratories, Seattle, WA, USA.
  • Bellizzi AM; Department of Pathology, Istituto Europeo di Oncologia IRCCS, Milan, Italy.
  • Brogi E; University of Milan, Milan, Italy.
  • Moore DA; Department of Pathology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Larsimont D; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Dillon DA; University of Milan, Milan, Italy.
J Pathol ; 250(5): 667-684, 2020 04.
Article in En | MEDLINE | ID: mdl-32129476
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Biomarkers, Tumor / Lymphocytes, Tumor-Infiltrating / B7-H1 Antigen / Triple Negative Breast Neoplasms Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Year: 2020 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Biomarkers, Tumor / Lymphocytes, Tumor-Infiltrating / B7-H1 Antigen / Triple Negative Breast Neoplasms Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Year: 2020 Type: Article